Biohit Oyj — Board/Management Information 2021

Jun 29, 2021

Constitutive meeting of Biohit Oyj’s Board of Directors

Constitutive meeting of Biohit Oyj’s Board of Directors

Biohit Oyj, Other information disclosed according to the rules of the Exchange,
June 29, 2021 at 9:30 am local time (EEST)

Biohit Oyj’s Board of Directors has in its meeting yesterday (28 June) elected
Commercial Counsellor Eero Lehti as the Chairman of the Board of Directors.

Additional information:
Deputy CEO Osmo Suovaniemi, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission
is “Innovating for Health” – we produce innovative products and services to
promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV)
is quoted on Nasdaq Helsinki in the Small cap/Healthcare
group. www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=ciyb_
iZ945H2z3sK3a9i7Zs03Nkj9jr5Brw7kC1tsoUye5PVgko06PC57Z9BVVT2pXUgp6sn
-tswLd2MUgQOQc8UNXD2BkNm3L02XzRJ7XfJCPaPUqGS1mpI0NZinK5T)